6Letters Launches “MOJO KING,” an Apple Watch-Based iOS App for Non-Invasive Testosterone Monitoring 
GeneNews Signs Global Licensing and Services Agreement with Oncore Pharma
TORONTO, ON / ACCESSWIRE / June 10, 2019 / GeneNews Limited (TSX: GEN), a life sciences company specializing in blood-based...
ProLung Announces New Office Location as Anchor Tenant at ‘The Labs at Northgate’
SALT LAKE CITY, UT / ACCESSWIRE / June 10, 2019 / ProLung, Inc. ("ProLung" or the "Company"), which is focused...
Boosting Existing Services and Operating More Efficiently is Top of Mind for Health Care Executives, Survey Finds
Proskauer launches new health care survey, exploring how close health care organizations are to achieving The Triple Aim as they...
Milestone Scientific’s CompuFlo(R) Epidural Instrument Featured in Multiple Abstracts at Euroanaesthesia 2019
Madrid hospital finds CompuFlo a reliable technique for blood patch procedures European School of Obstetric Anesthesia reports CompuFlo improves trainee...
CTD Announces Continuation of Expanded Access Program in Single Alzheimer’s Patient
Favorable risk/benefit analysis outlined in report to FDA ALACHUA, FL / ACCESSWIRE / June 10, 2019 / CTD Holdings, Inc....
New Jersey Lasik Surgeon Dr. Steven W. Stetson Returns to Paramus for Patient Surgeries
Dr. Stetson, Who is Medical Director of Diamond Vision, is Again Seeing Patients and Performing Surgery at the Paramus Office...
David Appell Joins Parallax Health Sciences, Inc. as Chief Operating Officer
Mr. Appell brings over twenty years of experience in building high volume transactional-related platforms to deliver large revenue streams SANTA...
Masimo Announces FDA Clearance of Neonatal Indication for O3® Regional Oximetry
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that O3® Regional Oximetry has received FDA clearance for use on neonatal and infant...
Medable and Synexus Announce Partnership to Launch Telemedicine Solution to Improve Patient Retention and Engagement in Data-Driven Virtual Clinical Trials
Medable to reduce dropout rate and improve patient retention in clinical trials with new telemedicine solution DIA 2019 Exhibit #2331...
Fractyl’s Revita DMR Same-Day Therapeutic Procedure Could End Daily Insulin Injections for Type 2 Diabetes Patients
Interim clinical data to be presented at ADA 2019 show that approximately 85 percent of patients are insulin-free at six...
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Quarter Ended 31 March 2019
Parnell Delivers 9% Revenue Growth in Quarter 1 of 2019 Compared to 2018, and Confirms Provisional 2019 Guidance for a...
DECN Discusses Propositions Received For Its GenUltimate TBG
LOS ANGELES, CA / ACCESSWIRE / June 7, 2019 / Decision Diagnostics Corp. (OTC PINK: DECN) is a 17 year...
MPPs to Pack Medicines for Refugees
OAKVILLE, ON / ACCESSWIRE / June 7, 2019 / Health Partners International of Canada (HPIC) will be hosting a delegation...
FDB to Share Insights on Maximizing the Use of Unique Device Identifiers at UDI Conference 2019
Patrick Lupinetti to Provide Expertise on how the UDI Rule is a Catalyst to Solve Problems, Promote New Developments, and...
Senseonics Announces FDA Approval for a Non-Adjunctive Indication (Dosing Claim) for the Eversense® 90-day CGM System
With a non-adjunctive claim, Eversense users will soon be able to manage their diabetes dosing decisions without confirming with fingersticks...
Arcutis, Inc. Appoints Scott Burrows as Vice President, Finance
WESTLAKE VILLAGE, CA / ACCESSWIRE / June 6, 2019 / Arcutis, Inc., a privately held immuno-dermatology drug development company addressing...
How Blockchain Can Boost Your Health
HONG KONG, CHINA / ACCESSWIRE / June 6, 2019 / Young, elderly, man, woman, dumb, wise, rich or poor no...
Streamline Health to Report First Quarter 2019 Financial Performance on June 12, 2019
ATLANTA, GA / ACCESSWIRE / June 5, 2019 / Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of integrated solutions, technology-enabled...
Adial Pharmaceuticals and Tedor Pharma Announce Collaboration to Manufacture AD04 Through Commercialization
Adial Reaffirms on Track to Commence Phase 3 Trial in Q3 2019 CHARLOTTESVILLE, VA / ACCESSWIRE / June 6, 2019...
DECN Accepts 4th Unsolicited Proposition for its GenUltimate TGB Product, and Today Launches its GenUltimate TGB Product into Select International Markets
DECN Awaits Major Proposition On Or About June 10, Notifies Two Entities That Their Earlier Propositions Do Not Meet Requirements,...